arrow
Back
E

Evan Y. Yu

university of washington

60H-index
560Paper Count
2.3WCitation Count
Published Papers 111
Publication Date
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations
err2025-12-06
err0
PREAI
errHeather H. Cheng; Sam Callis; Evan Y. Yu; Scott E. Delacroix; Alexandra O. Sokolova; Catherine M. Tangen; Seth P. Lerner; Tanya Barauskas Dorff; Daniel W. Lin
errShare
errSave
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study
err2025-11-01
err0
PREAI
errBakaloudi, Dimitra Rafailia; Koehne, Elizabeth L.; Voutsinas, Jenna M.; Diamantopoulos, Leonidas N.; Makrakis, Dimitrios; Grivas, Petros; True, Lawrence D.; Tretiakova, Maria S.; Vakar-Lopez, Funda; Psutka, Sarah P.; Holt, Sarah K.; Gore, John L.; Lin, Daniel W.; Schade, George R.; Nyame, Yaw A.; Hsieh, Andrew C.; Yezefski, Todd; Hawley, Jessica E.; Schweizer, Michael T.; Cheng, Heather H.; Yu, Evan Y.; Montgomery, R. Bruce; Wu, Qian; Wright, Jonathan L.
errShare
errSave
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis
err2025-11-01
err0
errOAAI
errEvan Y. Yu; Hiroyoshi Suzuki; Christopher M. Pieczonka; Geoffrey Gotto; Alberto Briganti; Murilo Luz; Declan Murphy; Ryan Malone; Joelle Hamilton; Jonathan E. Chan; Paul Sieber; Robert W. Given; Eva Hellmis; Thomas Kretz; Philipp Spiegelhalder; Antonio Gómez-Caamaño; Yaovi Messan Amela; Xavier Artignan; Hiroji Uemura; Naoki Fujita; Patrick Adorjan; Mercedeh Ghadessi; Frank Verholen; Andrew J. Armstrong
errShare
errSave
Validating Calibration of an Artificial Intelligence Assessment of Endoscopic Severity in Ulcerative Colitis
err2025-10-01
err0
PREAI
errBattioui, Chakib; Brodskiy, Pavel; Gottlieb, Klaus; Haft-Javaherian, Mohammad; Eastman, William J.; Lehrer, Julian; Yu, Evan; Onken, Derek; Thomason, Darren; Reinisch, Walter; Colucci, Daniel; Baxi, Shrujal
errShare
errSave
Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma
err2025-08-11
err0
errOAAI
errM.S. van der Heijden; T. Powles; S. Gupta; Y. Loriot; M.D. Galsky; B.P. Valderrama; S.S. Sridhar; E.Y. Yu; G. Iyer; E. Kikuchi; D. Castellano; J. Hoffman-Censits; A. Drakaki; N. Mar; J.P. Maroto Rey; C. Vulsteke; W. Arafat; I. Duran; N.A. Dawson; U. Swami; S. Gorla; B.H. Moreno; X. Yu; Y.-T. Lu; J. Bedke
errShare
errSave
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer
err2025-07-19
err0
errOAAI
errNiven Mehra; Emmanuel S. Antonarakis; Se Hoon Park; Jeffrey C. Goh; Ray McDermott; Nuria Sala Gonzalez; Peter C. Fong; Richard Greil; Maria De Santis; Patricio Eduardo Yanez; Yi-Hsiu Huang; Stephen D. Begbie; Felipe Rey; Gero Kramer; Hiroyoshi Suzuki; Todd L. Saretsky; Sameer R. Ghate; Yi Cui; Christian Hosius; Evan Y. Yu
errShare
errSave
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
err2025-02-07
err0
PREAI
errRuben Raychaudhuri; Abuzar Moradi Tuchayi; Soon Khai Low; Ali T. Arafa; Laura S. Graham; Roman Gulati; Colin C. Pritchard; Robert B. Montgomery; Michael C. Haffner; Peter S. Nelson; Evan Y. Yu; Jessica E. Hawley; Heather H. Cheng; George Mo; Delphine L. Chen; Emmanuel S. Antonarakis; Deepak Kilari; Thomas A. Hope; Amir Iravani; Michael T. Schweizer
errShare
errSave
Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial
err2024-12-01
err0
PREAI
errRosenberg, J. E.; Galsky, M. D.; Powles, T.; Petrylak, D. P.; Bellmunt, J.; Loriot, Y.; Necchi, A.; Hoffman-Censits, J.; Perez-Gracia, J. L.; van der Heijden, M. S.; Dreicer, R.; Duran, I.; Castellano, D.; Drakaki, A.; Retz, M.; Sridhar, S. S.; Grivas, P.; Yu, E. Y.; O'Donnell, H.; Burris, H. A.; Mariathasan, S.; Shi, Y.; Goluboff, E.; Bajorin, D.
errShare
errSave
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG-Avid Discordant Findings
err2024-11-14
err1
PREAI
errDemirci, Ridvan Arda; Ghodsi, Alireza; Gulati, Roman; Behnia, Sanaz; Nelson, Peter S.; Cheng, Heather H.; Yezefski, Todd A.; Haffner, Michael C.; Hawley, Jessica E.; Montgomery, Robert B.; Yu, Evan Y.; Schweizer, Michael T.; Chen, Delphine L.; Iravani, Amir
errShare
errSave
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617
err2024-11-07
err0
PREAI
errDemirci, Ridvan Arda; Gulati, Roman; Hawley, Jessica E.; Yezefski, Todd; Haffner, Michael C.; Cheng, Heather H.; Montgomery, Robert B.; Schweizer, Michael T.; Yu, Evan Y.; Nelson, Peter S.; Chen, Delphine L.; Iravani, Amir
errShare
errSave
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
err2024-10-15
err0
errOAAI
errHamilton, Erika; Galsky, Matthew D.; Ochsenreither, Sebastian; Del Conte, Gianluca; Martin, Miguel; De Miguel, Maria Jose; Yu, Evan Y.; Williams, Anja; Gion, Maria; Tan, Antoinette R.; Agrawal, Laila; Rutten, Annemie; Machiels, Jean-Pascal; Cresta, Sara; Debruyne, Philip R.; Hennequin, Audrey; Moreno, Victor; Minchom, Anna; Valdes-Albini, Frances; Petrylak, Daniel; Li, Li; Tsuchihashi, Zenta; Suto, Fumitaka; Cheng, Fu-Chih; Kandil, Maha; Barrios, Daniel; Hurvitz, Sara
errShare
errSave
Tucatinib and Trastuzumab for Patients With Previously Treated, HER2-Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study
err2024-10-01
err0
PREAI
errNakamura, Y.; Bekaii-Saab, T.; Hamilton, E.; Hayashi, H.; Mizuno, N.; Monk, B. J.; Nguyen, D.; Okines, A.; O'Malley, D. M.; Pohlmann, P. R.; Pothuri, B.; Reck, M.; Sudo, K.; Sunakawa, Y.; Takahashi, S.; Yu, E. Y.; Drees, A.; Tan, S.; Stinchcombe, T. E.
errShare
errSave
Head-to-Head Evaluation of Two Machine Learning Algorithms for Predicting Endoscopic Mayo Score in Ulcerative Colitis
err2024-10-01
err0
PREAI
errBattioui, Chakib; Brodskiy, Pavel; Gottlieb, Klaus; Haft-Javaherian, Mohammad; Baxi, Shrujal; Yu, Evan
errShare
errSave
PSMA-targeted radioligand therapy (RLT) with 131I-LNTH-1095 (1095) plus enzalutamide (enza) vs enza alone in chemotherapy-naive patients (pts) whose piflufolastat F 18-avid metastatic castration-resistant prostate cancer (mCRPC) progressed on abiraterone (abi): ARROW
err2024-09-01
err0
PREAI
errYu, E. Y.; Narayan, V.; Esposito, G.; Szmulewitz, R.; Lu, Y.; Lilly, M.; Calais, J.; Bratslavsky, G.; Vasanawala, M.; Ulaner, G. A.; Pouliot, F.; Laidley, D.; Fleshner, N.; Saad, F.; Menda, Y.
errShare
errSave
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study
err2024-06-01
err0
errOAAI
errYu, Evan Y.; Berry, William R.; Gurney, Howard; Retz, Margitta; Conter, Henry J.; Laguerre, Brigitte; Fong, Peter C. C.; Ferrario, Cristiano; Todenhofer, Tilman; Gravis, Gwenaelle; Piulats, Josep M.; Emmenegger, Urban; Shore, Neal D.; Romano, Emanuela; Mourey, Loic; Li, Xin Tong; Poehlein, Christian H.; Schloss, Charles; Appleman, Leonard J.; Bono, Johann S. de
errShare
errSave
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial
err2024-06-01
err0
errOAAI
errPowles, Thomas; Chang, Yen-Hwa; Yamamoto, Yoshiaki; Munoz, Jose; Reyes-Cosmelli, Felipe; Peer, Avivit; Cohen, Graham; Yu, Evan Y.; Lorch, Anja; Bavle, Abhishek; Moreno, Blanca Homet; Markensohn, Julia; Edmondson, Mackenzie; Chen, Cai; Cristescu, Razvan; Pena, Carol; Lunceford, Jared; Gunduz, Seyda
errShare
errSave
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
err2024-05-17
err3
errOAAI
errAjkunic, Azra; Sayar, Erolcan; Roudier, Martine P.; Patel, Radhika A.; Coleman, Ilsa M.; De Sarkar, Navonil; Hanratty, Brian; Adil, Mohamed; Zhao, Jimmy; Zaidi, Samir; True, Lawrence D.; Sperger, Jamie M.; Cheng, Heather H.; Yu, Evan Y.; Montgomery, Robert B.; Hawley, Jessica E.; Ha, Gavin; Persse, Thomas; Galipeau, Patricia; Lee, John K.; Harmon, Stephanie A.; Corey, Eva; Lang, Joshua M.; Sawyers, Charles L.; Morrissey, Colm; Schweizer, Michael T.; Gulati, Roman; Nelson, Peter S.; Haffner, Michael C.
errShare
errSave
THIRD INTERIM ANALYSIS (IA3) OF THE DAROLUTAMIDE OBSERVATIONAL (DAROL) STUDY IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)
err2024-05-01
err0
PREAI
errGotto, Geoffrey; Suzuki, Hiroyoshi; Luz, Murilo; Briganti, Alberto; Yu, Evan Y.; Pieczonka, Christopher; Murphy, Declan; Malone, Ryan; Hamilton, Joelle; Chan, Jonathan E.; Sieber, Paul; Given, Robert W.; Adorjan, Patrick; Ghadessi, Mercedeh; Verholen, Frank; Armstrong, Andrew J.
errShare
errSave
Interim results of the ongoing phase 1-2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors
err2024-04-05
err0
PREAI
errYu, Evan Y.; Henry, Jason; Patel, Manish R.; Swiecicki, Paul; Micaily, Ida; Garmezy, Benjamin; Banda, Kalyan; Hayreh, Vinny; Lustig, Kurt; Ovechkina, Yulia; Iadonato, Shawn P.; Guillaudeux, Thierry; Rosen, Lee
errShare
errSave
A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) vs. atezo alone in patients with locally advanced or metastatic urothelial carcinoma (mUC)
err2023-10-01
err0
errOAAI
errPachynski, R.; Chatta, G.; Jain, R. K.; Moon, H.; Sweis, R.; Delacroix, S.; Fang, T.; Fling, S. P.; Lacroix, A.; Kaiser, J.; Sharon, E.; Yu, E.
errShare
errSave